 <h1>Capecitabine Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of capecitabine include:</b> anemia, diarrhea, hyperbilirubinemia, increased serum alkaline phosphatase, increased serum transaminases, nausea, neutropenia, palmar-plantar erythrodysesthesia, paresthesia, stomatitis, thrombocytopenia, and vomiting. <b>Other side effects include:</b> erythema of skin.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to capecitabine: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Patients receiving concomitant capecitabine and oral coumarin-derivative anticoagulant therapy should be monitored frequently for anticoagulant response (INR or prothrombin time) and the anticoagulant dose should be adjusted accordingly. Altered coagulation parameters and bleeding, including fatal cases, have been reported in patients taking capecitabine concomitantly with coumarin-derivative anticoagulants such as warfarin or phenprocoumon. These events occurred in patients with and without liver metastases and within several days to several months after initiating capecitabine therapy; however, in a few cases the events occurred within 1 month of discontinuation. Age greater than 60 years and a diagnosis of cancer independently predispose patients to an increased risk of coagulopathy.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, capecitabine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking capecitabine:</p><p>
<i>More common</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>diarrhea</li>
<li>loss of fingerprints</li>
<li>nausea</li>
<li>numbness, pain, tingling, or other unusual sensations in the palms of the hands or bottoms of the feet</li>
<li>pain, blistering, peeling, redness, or swelling of the palms of the hands or bottoms of the feet</li>
<li>pain, redness, swelling, sores, or ulcers in your mouth or on your lips</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common or rare</i>
</p><ul>
<li>Abdominal or stomach cramping or pain (severe)</li>
<li>agitation</li>
<li>back pain</li>
<li>bleeding and bruising</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>bloody nose</li>
<li>bloody or black, tarry stools</li>
<li>blurred vision</li>
<li>burning, dry, or itching eyes</li>
<li>chest pain</li>
<li>chills</li>
<li>clumsiness or unsteadiness</li>
<li>cold</li>
<li>collapse</li>
<li>coma</li>
<li>confusion</li>
<li>constipation</li>
<li>convulsions</li>
<li>cough or hoarseness (accompanied by fever or chills)</li>
<li>cough producing mucus</li>
<li>coughing or spitting up blood</li>
<li>dark urine</li>
<li>decreased frequency or amount of urine</li>
<li>difficulty with breathing</li>
<li>difficulty with swallowing or pain in the back of throat or chest when swallowing</li>
<li>discharge from the eyes</li>
<li>drowsiness</li>
<li>dry mouth</li>
<li>excessive tearing</li>
<li>extra heartbeats</li>
<li>eye redness, irritation, or pain</li>
<li>fainting</li>
<li>fast or irregular heartbeat</li>
<li>fever or chills</li>
<li>flu-like symptoms</li>
<li>hallucinations</li>
<li>headache, sudden and severe</li>
<li>heavier menstrual periods</li>
<li>high fever</li>
<li>hot, red skin on the feet or legs</li>
<li>inability to speak</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>increased thirst</li>
<li>irritability</li>
<li>itching in the genital or other skin areas</li>
<li>lightheadedness</li>
<li>light-colored stools</li>
<li>loss of consciousness</li>
<li>lower back or side pain (accompanied by fever or chills)</li>
<li>muscle aches or cramps</li>
<li>muscle spasms</li>
<li>nosebleeds</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>painful or difficult urination (accompanied by fever or chills)</li>
<li>painful, swollen feet or legs</li>
<li>pain, tenderness, or swelling in the upper abdominal or stomach area</li>
<li>pale skin</li>
<li>paralysis</li>
<li>pinpoint red spots on the skin</li>
<li>problems with coordination</li>
<li>prolonged bleeding from cuts</li>
<li>rapid, shallow breathing</li>
<li>red or dark brown urine</li>
<li>redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>scaling</li>
<li>seizures</li>
<li>severe constipation</li>
<li>skin rash or itching</li>
<li>slow or irregular heartbeat</li>
<li>slurred speech</li>
<li>sneezing, sore throat, or stuffy nose</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>stiff neck</li>
<li>stomach bloating, burning, or cramping</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>swelling of the lymph nodes</li>
<li>swollen glands</li>
<li>temporary blindness</li>
<li>tiredness or weakness</li>
<li>trouble with speaking</li>
<li>troubled breathing or tightness in the chest</li>
<li>unexplained nosebleeds</li>
<li>unusual bleeding or bruising</li>
<li>unusual lump or swelling in the chest</li>
<li>vomiting blood or material that looks like coffee grounds</li>
<li>weakness in the arm or leg on one side of the body, sudden and severe</li>
<li>weight gain or loss</li>
<li>white patches in the mouth or throat or on the tongue</li>
<li>white patches with diaper rash</li>
<li>yellow eyes or skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Chest discomfort, tightness, or heaviness</li>
<li>dilated neck veins</li>
<li>dizziness</li>
<li>extreme fatigue</li>
<li>irregular breathing</li>
<li>no blood pressure or pulse</li>
<li>pain or discomfort in the arms, jaw, back, or neck</li>
<li>stopping of heart</li>
<li>sweating</li>
<li>unconsciousness</li>
<li>weight gain</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of capecitabine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Burning, crawling, itching, numbness, prickling, “pins and needles”, or tingling feelings</li>
<li>changes or discoloration in the fingernails or toenails</li>
<li>difficulty with moving</li>
<li>discouragement</li>
<li>headache</li>
<li>heartburn</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>muscle pain</li>
<li>pain</li>
<li>pain and redness of the skin at the place of x-ray treatment</li>
<li>pain in the joints or limbs</li>
<li>red, sore eyes</li>
<li>sunken eyes</li>
<li>thirst</li>
<li>trouble sleeping</li>
<li>weakness</li>
<li>wrinkled skin</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bone pain</li>
<li>change in color of treated skin</li>
<li>difficulty with walking</li>
<li>discouragement</li>
<li>feeling of constant movement of self or surroundings</li>
<li>feeling sad or empty</li>
<li>full or bloated feeling or pressure in the stomach</li>
<li>general feeling of discomfort or illness</li>
<li>hot flushes</li>
<li>impaired balance</li>
<li>increased sweating</li>
<li>joint pain</li>
<li>lack of appetite</li>
<li>loss of interest or pleasure</li>
<li>muscle weakness</li>
<li>noisy breathing</li>
<li>pain in the rectum</li>
<li>pain, swelling, or redness in the joints</li>
<li>passing less gas</li>
<li>rough, scratchy sound to voice</li>
<li>runny nose</li>
<li>sensation of spinning</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>shivering</li>
<li>sores on the skin</li>
<li>swelling of abdominal or stomach area</li>
<li>tremor or shaking of the hands or feet</li>
<li>trouble concentrating</li>
<li>voice changes</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to capecitabine: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Thrombosis/embolism, hypertension, lower limb edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Angina unstable, angina pectoris, myocardial ischemia/infarction, atrial fibrillation, arrhythmia, tachycardia, sinus tachycardia, palpitations, peripheral edema, chest pain, hypertensive crisis</p>
<p><b>Rare</b> (less than 0.1%): Ventricular fibrillation, QT prolongation, Torsade de pointes, bradycardia, vasospasm<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hand-and-foot syndrome (up to 63%), alopecia (up to 41%), dermatitis (up to 27%), nail disorder (up to 14%)</p>
<p><b>Common</b> (1% to 10%): Rash, erythema, skin discoloration, dermatitis, onycholysis, pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Blister, skin ulcer, rash, urticaria, photosensitivity reaction, palmar erythema, swelling face, purpura, radiation recall syndrome</p>
<p><b>Very rare</b> (less than 0.01%): Cutaneous lupus erythematosus, severe skin reactions such as Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (TEN)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 67%), stomatitis (up to 67%), nausea (up to 45%), vomiting (up to 35%), abdominal pain (up to 35%), constipation, (up to 20%), GI motility disorder (up to 10%), dyspepsia</p>
<p><b>Common</b> (1% to 10%): Upper abdominal pain, lower abdominal pain, upper GI inflammatory disorders, upper GI hemorrhage, ileus, dry mouth, mouth ulceration, gastritis, abdominal distension, gastroesophageal reflux disease, oral pain, dysphagia, rectal hemorrhage, oral dysesthesia, oral paresthesia, oral hypoesthesia</p>
<p><b>Uncommon</b> (0.1% to 1%): Tonsillitis, oral candidiasis, gastroenteritis, tooth abscess</p>
<p><b>Rare</b> (0.01% to 0.1%): Intestinal obstruction, ascites, enteritis, esophagitis, colitis<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse reactions were GI disorders (especially diarrhea, nausea, vomiting, abdominal pain, and stomatitis), hand-foot syndrome (palmar-plantar erythrodysesthesia), fatigue, asthenia, anorexia, cardiotoxicity, increased renal dysfunction in those with preexisting compromised renal function, and thrombosis/embolism.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, libido decreased, dysuria</p>
<p><b>Rare</b> (0.01% to 0.1%): Hydronephrosis, urinary incontinence, hematuria, nocturia, vaginal hemorrhage<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (up to 80%), leukopenia, (up to 13%), neutropenia (up to 13%), febrile neutropenia, thrombocytopenia</p>
<p><b>Common</b> (1% to 10%): Decreased platelets</p>
<p><b>Uncommon</b> (0.1% to 1%): Granulocytopenia, hemolytic anemia, International Normalized Ratio (INR) increased/Prothrombin time prolonged, phlebitis</p>
<p><b>Rare</b> (0.01% to 0.1%): Deep vein thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Hyperbilirubinemia (up to 48%) </p>
<p><b>Common</b> (1% to 10%): Increased ALAT (SGPT)</p>
<p><b>Uncommon</b> (0.1% to 1%): Jaundice</p>
<p><b>Very rare</b> (less than 0.01%): Hepatic failure, cholestatic hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infections, oral candidiasis, herpes viral infection, influenza-like illness</p>
<p><b>Uncommon</b> (0.1% to 1%): Sepsis, cellulitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction, injection site reaction, infusion site pain, injection site pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 26%)</p>
<p><b>Common</b> (1% to 10%): Dehydration, hypokalemia, weight loss, hyponatremia, hypomagnesemia, hypocalcemia, hypercalcemia, hyperglycemia</p>
<p><b>Uncommon</b> (0.1% to 1%): Diabetes, appetite disorder, malnutrition, hypertriglyceridemia</p>
<p><b>Rare</b> (0.01% to 0.1%): Blood creatinine increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 10%), arthralgia, myalgia</p>
<p><b>Common</b> (1% to 10%): Chest pain (noncardiac), pain in jaw, pain in extremity</p>
<p><b>Uncommon</b> (0.1% to 1%): Joint swelling, bone pain, facial pain, musculoskeletal stiffness, muscular weakness, muscle spasms<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Taste disturbance (up to 16%), headache (up to 15%), paresthesia (up to 12%), dizziness (up to 12%), neuropathy (up to 10%), peripheral neuropathy, peripheral sensory neuropathy, dysgeusia, dysesthesia </p>
<p><b>Common</b> (1% to 10%): Dizziness, hypoesthesia</p>
<p><b>Rare</b> (0.01% to 0.1%): Aphasia, memory impairment, ataxia, syncope, balance disorder, sensory disorder</p>
<p><b>Very rare</b> (less than 0.01%): Toxic leukoencephalopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye irritation (13%)</p>
<p><b>Common</b> (1% to 10%): Abnormal vision, lacrimation increased, conjunctivitis</p>
<p><b>Uncommon</b> (0.1% to 1%): Visual acuity reduced, diplopia, dry eye, eye pain, visual impairment</p>
<p><b>Rare</b> (0.01% to 0.1%): Lacrimal duct stenosis, corneal disorders, keratitis, punctate keratitis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lipoma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/weakness (up to 42%), pyrexia (up to 28%), edema (up to 15%), pain (up to 12%), asthenia (up to 26%), lethargy (up to 10%), temperature intolerance, tinnitus, hypoacusis, hot flush, flushing, peripheral coldness</p>
<p><b>Uncommon</b> (0.1% to 1%): Vertigo, ear pain</p>
<p><b>Rare</b> (0.01% to 0.1%): Chills, edema, malaise, rigors<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood alteration, depression, sleep disorder, insomnia, anxiety</p>
<p><b>Uncommon</b> (0.1% to 1%): Confusional state, panic attack<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Hematuria, proteinuria, creatinine renal clearance decreased</p>
<p><b>Rare</b> (0.01% to 0.1%): Acute renal failure secondary to dehydration including fatal outcomes<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (up to 14%), dysesthesia pharynx, sore throat</p>
<p><b>Common</b> (1% to 10%): Epistaxis, cough, pharyngeal disorder, dysphonia, rhinorrhea, nasopharyngitis, lower respiratory tract infection, hiccups</p>
<p><b>Uncommon</b> (0.1% to 1%): Pulmonary embolism, pneumothorax, hemoptysis, asthma, dyspnea exertional<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Xeloda (capecitabine)." Roche Laboratories, Nutley, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about capecitabine</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>38 Reviews</li>
<li>Drug class: antimetabolites</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Capecitabine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Xeloda</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer, Metastatic</li>
<li>Colorectal Cancer</li>
<li>Anal Cancer</li>
<li>Breast Cancer</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to capecitabine: oral tablet</i></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Thrombosis/embolism, hypertension, lower limb edema</p><p><b>Uncommon</b> (0.1% to 1%): Angina unstable, angina pectoris, myocardial ischemia/infarction, atrial fibrillation, arrhythmia, tachycardia, sinus tachycardia, palpitations, peripheral edema, chest pain, hypertensive crisis</p><p><b>Rare</b> (less than 0.1%): Ventricular fibrillation, QT prolongation, Torsade de pointes, bradycardia, vasospasm<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Hand-and-foot syndrome (up to 63%), alopecia (up to 41%), dermatitis (up to 27%), nail disorder (up to 14%)</p><p><b>Common</b> (1% to 10%): Rash, erythema, skin discoloration, dermatitis, onycholysis, pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Blister, skin ulcer, rash, urticaria, photosensitivity reaction, palmar erythema, swelling face, purpura, radiation recall syndrome</p><p><b>Very rare</b> (less than 0.01%): Cutaneous lupus erythematosus, severe skin reactions such as Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis (TEN)<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (up to 67%), stomatitis (up to 67%), nausea (up to 45%), vomiting (up to 35%), abdominal pain (up to 35%), constipation, (up to 20%), GI motility disorder (up to 10%), dyspepsia</p><p><b>Common</b> (1% to 10%): Upper abdominal pain, lower abdominal pain, upper GI inflammatory disorders, upper GI hemorrhage, ileus, dry mouth, mouth ulceration, gastritis, abdominal distension, gastroesophageal reflux disease, oral pain, dysphagia, rectal hemorrhage, oral dysesthesia, oral paresthesia, oral hypoesthesia</p><p><b>Uncommon</b> (0.1% to 1%): Tonsillitis, oral candidiasis, gastroenteritis, tooth abscess</p><p><b>Rare</b> (0.01% to 0.1%): Intestinal obstruction, ascites, enteritis, esophagitis, colitis<sup>[Ref]</sup></p><h3>General</h3><p>The most commonly reported adverse reactions were GI disorders (especially diarrhea, nausea, vomiting, abdominal pain, and stomatitis), hand-foot syndrome (palmar-plantar erythrodysesthesia), fatigue, asthenia, anorexia, cardiotoxicity, increased renal dysfunction in those with preexisting compromised renal function, and thrombosis/embolism.<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection, libido decreased, dysuria</p><p><b>Rare</b> (0.01% to 0.1%): Hydronephrosis, urinary incontinence, hematuria, nocturia, vaginal hemorrhage<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (up to 80%), leukopenia, (up to 13%), neutropenia (up to 13%), febrile neutropenia, thrombocytopenia</p><p><b>Common</b> (1% to 10%): Decreased platelets</p><p><b>Uncommon</b> (0.1% to 1%): Granulocytopenia, hemolytic anemia, International Normalized Ratio (INR) increased/Prothrombin time prolonged, phlebitis</p><p><b>Rare</b> (0.01% to 0.1%): Deep vein thrombosis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Hyperbilirubinemia (up to 48%) </p><p><b>Common</b> (1% to 10%): Increased ALAT (SGPT)</p><p><b>Uncommon</b> (0.1% to 1%): Jaundice</p><p><b>Very rare</b> (less than 0.01%): Hepatic failure, cholestatic hepatitis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Hypersensitivity<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infections, oral candidiasis, herpes viral infection, influenza-like illness</p><p><b>Uncommon</b> (0.1% to 1%): Sepsis, cellulitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion related reaction, injection site reaction, infusion site pain, injection site pain<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Anorexia (up to 26%)</p><p><b>Common</b> (1% to 10%): Dehydration, hypokalemia, weight loss, hyponatremia, hypomagnesemia, hypocalcemia, hypercalcemia, hyperglycemia</p><p><b>Uncommon</b> (0.1% to 1%): Diabetes, appetite disorder, malnutrition, hypertriglyceridemia</p><p><b>Rare</b> (0.01% to 0.1%): Blood creatinine increased<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (up to 10%), arthralgia, myalgia</p><p><b>Common</b> (1% to 10%): Chest pain (noncardiac), pain in jaw, pain in extremity</p><p><b>Uncommon</b> (0.1% to 1%): Joint swelling, bone pain, facial pain, musculoskeletal stiffness, muscular weakness, muscle spasms<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Taste disturbance (up to 16%), headache (up to 15%), paresthesia (up to 12%), dizziness (up to 12%), neuropathy (up to 10%), peripheral neuropathy, peripheral sensory neuropathy, dysgeusia, dysesthesia </p><p><b>Common</b> (1% to 10%): Dizziness, hypoesthesia</p><p><b>Rare</b> (0.01% to 0.1%): Aphasia, memory impairment, ataxia, syncope, balance disorder, sensory disorder</p><p><b>Very rare</b> (less than 0.01%): Toxic leukoencephalopathy<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Eye irritation (13%)</p><p><b>Common</b> (1% to 10%): Abnormal vision, lacrimation increased, conjunctivitis</p><p><b>Uncommon</b> (0.1% to 1%): Visual acuity reduced, diplopia, dry eye, eye pain, visual impairment</p><p><b>Rare</b> (0.01% to 0.1%): Lacrimal duct stenosis, corneal disorders, keratitis, punctate keratitis<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Lipoma<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/weakness (up to 42%), pyrexia (up to 28%), edema (up to 15%), pain (up to 12%), asthenia (up to 26%), lethargy (up to 10%), temperature intolerance, tinnitus, hypoacusis, hot flush, flushing, peripheral coldness</p><p><b>Uncommon</b> (0.1% to 1%): Vertigo, ear pain</p><p><b>Rare</b> (0.01% to 0.1%): Chills, edema, malaise, rigors<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Mood alteration, depression, sleep disorder, insomnia, anxiety</p><p><b>Uncommon</b> (0.1% to 1%): Confusional state, panic attack<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Hematuria, proteinuria, creatinine renal clearance decreased</p><p><b>Rare</b> (0.01% to 0.1%): Acute renal failure secondary to dehydration including fatal outcomes<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (up to 14%), dysesthesia pharynx, sore throat</p><p><b>Common</b> (1% to 10%): Epistaxis, cough, pharyngeal disorder, dysphonia, rhinorrhea, nasopharyngitis, lower respiratory tract infection, hiccups</p><p><b>Uncommon</b> (0.1% to 1%): Pulmonary embolism, pneumothorax, hemoptysis, asthma, dyspnea exertional<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Xeloda (capecitabine)." Roche Laboratories, Nutley, NJ. </p><h2>More about capecitabine</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>38 Reviews</li>
<li>Drug class: antimetabolites</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Capecitabine &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Breast Cancer, Metastatic</li>
<li>Colorectal Cancer</li>
<li>Anal Cancer</li>
<li>Breast Cancer</li>
<li data-more-config-id="list-data-resources-conditions">... +5 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>